Iovance Biotherapeutics (2LB) Q3 2024 Earnings Report
DE:2LB Q3 2024 EPS Results
- Actual EPS
- -EUR 0.25
- Consensus EPS
- -EUR 0.27
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.41
DE:2LB Q3 2024 Revenue Results
- Actual Revenue
- EUR 52.43M
- Expected Revenue
- EUR 48.16M
- Beat/Miss
- Beat by +EUR 4.27M
- YoY Revenue Growth
- +12385.07%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/07/2024
- Time
- After Close
- Conference Call
- Thursday, November 7, 2024
DE:2LB Upcoming Earnings
Iovance Biotherapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
DE:2LB Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2LB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -0.08- | -0.22 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.12-0.10 | -0.3 | 66.67% (+0.20) | |
| May 07, 2026 | 2026 (Q1) | -0.14-0.17 | -0.32 | 47.22% (+0.15) | |
| Feb 24, 2026 | 2025 (Q4) | -0.16-0.16 | -0.23 | 30.77% (+0.07) | |
| Nov 06, 2025 | 2025 (Q3) | -0.23-0.22 | -0.25 | 10.71% (+0.03) | |
| Aug 07, 2025 | 2025 (Q2) | -0.25-0.30 | -0.3 | 2.94% (+0.01) | |
| May 08, 2025 | 2025 (Q1) | -0.22-0.32 | -0.38 | 14.29% (+0.05) | |
| Feb 27, 2025 | 2024 (Q4) | -0.24-0.23 | -0.4 | 42.22% (+0.17) | |
| Nov 07, 2024 | 2024 (Q3) | -0.27-0.25 | -0.41 | 39.13% (+0.16) | |
| Aug 08, 2024 | 2024 (Q2) | -0.32-0.30 | -0.42 | 27.66% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
